782016001: Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Neostigmine-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Quaternary ammonium compound-containing product\Glycopyrronium-containing product\...

\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Product manufactured as parenteral dose form\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product manufactured as parenteral dose form\Neostigmine-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Autonomic agent\Parasympathomimetic agent-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Autonomic agent\Parasympathomimetic agent-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Autonomic agent\Parasympathomimetic agent-containing product\Acetylcholinesterase inhibitor-containing product\Reversible anticholinesterase-containing product\Neostigmine-containing product\Neostigmine-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Glycopyrronium and neostigmine only product in parenteral dose form\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3752320013 Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym Active Initial character case insensitive SNOMED CT core

3752321012 Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym Active Initial character case insensitive SNOMED CT core

3752322017 Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has manufactured dose form	Solution for injection	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator value	500	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Is a	Glycopyrronium and neostigmine only product in parenteral dose form	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has BoSS	Glycopyrrolate	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Count of base of active ingredient	2	false	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mcg	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Glycopyrrolate	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator value	2.5	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has BoSS	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mg	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has BoSS	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Glycopyrrolate	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has BoSS	Glycopyrrolate	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3752320013	Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3752321012	Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3752322017	Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core